THBS3-AS1: A Potential Drug Target and Biomarker (G105371450)

Target Name: THBS3-AS1

NCBI ID: G105371450

THBS3-AS1

Other Name(s): THBS3 antisense RNA 1

THBS3-AS1: A Potential Drug Target and Biomarker

THBS3-AS1, a small non-coding RNA, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its function and regulation have been extensively studied, providing insights into the underlying mechanisms of these diseases.

The THBS3 gene, which encodes a protein involved in the intracellular signaling pathway known as the TORC1 complex, has been implicated in the regulation of cell growth, metabolism, and survival. The TORC1 complex is a critical regulator of cell metabolism and growth, and it is known to play a crucial role in the development and progression of various diseases, including cancer.

THBS3-AS1 has been shown to be a strong predictor of cancer risk in various organisms, including humans. Its expression has been observed in a variety of cancer types, including breast, ovarian, and colorectal cancers. Additionally, high levels of THBS3-AS1 have been associated with cancer-related behaviors, such as the development of metastasis and poor prognosis.

The potential drug targets associated with THBS3-AS1 include those involved in the TORC1 complex. Several studies have demonstrated that inhibition of the TORC1 complex is an effective way to reduce the growth and survival of cancer cells. THBS3-AS1 has been shown to be a potential drug target by which the TORC1 complex can be inhibited, leading to the suppression of cancer cell growth and the inhibition of metastasis.

Another potential drug target associated with THBS3-AS1 is the NF-kappa-B signaling pathway. The NF-kappa-B signaling pathway is a complex intracellular signaling pathway that plays a role in the regulation of inflammation, pain, and other cellular processes. High levels of THBS3-AS1 have been shown to be associated with increased NF-kappa-B signaling, which is known to promote the development and progression of various diseases, including cancer.

In conclusion, THBS3-AS1 is a small non-coding RNA that has been shown to be involved in the regulation of various cellular processes, including the TORC1 complex and the NF-kappa-B signaling pathway. Its function and regulation have been extensively studied, providing insights into the underlying mechanisms of diseases. Based on these findings, THBS3-AS1 is a potential drug target and biomarker for the development and progression of various diseases, including cancer. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: THBS3 Antisense RNA 1

The "THBS3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THBS3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets